Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1844370 | 0.88 | TSHR (0.38) | ALOX15ALOX12 | |
| SCHEMBL2017623 | 0.88 | GABRA1 (0.38) | ALOX15ALOX12 | |
| SCHEMBL2025112 | 0.79 | TSHR (0.49) | ALOX15ALOX12 | |
| SCHEMBL2019657 | 0.79 | TSHR (0.41) | ALOX15ALOX12ESR1ESR2 | |
| SCHEMBL2021097 | 0.79 | PRKCI (0.36) | ALOX15 | |
| SCHEMBL1843993 | 0.78 | GABRA1 (0.40) | — | |
| SCHEMBL2018232 | 0.77 | TYR (0.43) | ALOX15 | |
| SCHEMBL1954274 | 0.74 | ALOX15 (0.34) | ALOX15ALOX12ESR1ESR2 | |
| SCHEMBL2025317 | 0.74 | ALOX15 (0.34) | ALOX15ALOX12 | |
| SCHEMBL2022483 | 0.74 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | ALOX15 464/4885ALOX12 470/4885ESR1 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.